WHO Approves Game-Changing Malaria Vaccine for Children: Fight Against Malaria

The World Health Organization “WHO” has approved a new malaria vaccine designed to protect children Which is  Known as R21. The vaccine is being developed through the University of Oxford and provides drought in the fight against malaria an epidemic transmitted by certain mosquitoes.
Malaria has long been a serious health problem, especially for infants and children. The good news is that more than 100,000 doses of this new drug are already being planned annually.

Malaria is caused by an insidious virus that is contracted during mosquito bites. This pathogen allows us to change shape in our bodies, making it harder for our immune system to truly fight the contaminants.


Read More: Health update on Haris Rauf and Naseem Shah

Developing a vaccine for delivery has been a long and difficult  process. What makes this new vaccine unique is that it can be mass-produced through the University of Oxford. Indian Serum Institute, the world’s largest vaccine manufacturer, is planning to produce more than 100 million according to the yr and wants to increase that number to 20 million each dose costs $2-4 cheapest and ready to be part of the previously agreed upon range. There were 247 million people infected with malaria by 2021.


Read More: Best food intake for Healthy Heart


Unfortunately, 619,000 people, usually children under five, had not been misplaced by the disease. The new R21 vaccine showed promising results when it doesn’t fit into the typical scientific research process WTO Regional Director for Africa, Dr. Matshidiso Moeti believes this new vaccine is great compare with previous vaccines